In an interview, HLTH's Head of Content Jody Tropeano shares how the annual conference has adopted a festival-like vibe with an innovative layout to maximize interaction, with content highlighting topics such as women's health, wellness, and employer health.
The HLTH conference has much to offer startups and investors at the early and growth stage, from networking opportunities, turnkey exhibits, compelling content, pitch contests, an Innovators’ Reception, exclusive pricing and more. Register today!
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
An analyst wrote that a best-case scenario for Amarin is that it may take 2-3 years for generic versions of Vascepa to hit the market. But the company has likely lost its luster as an acquisition target.
Spectrum said the FDA had accepted its application for Rolontis, which had shown non-inferiority to Amgen's Neulasta in Phase III testing. However, oncologists expressed mixed opinions about the drug.
Poziotinib did not show an improved response rate among previously treated non-small cell lung cancer patients with a specific genetic mutation, but additional cohorts in the Phase II study are ongoing.
Here's a preview of the agenda and speakers for the ENGAGE at HLTH conference, a joint collaboration between MedCity News and HLTH.
MedCity News and HLTH have teamed up to present MedCity’s annual patient engagement event ENGAGE at the second annual HLTH conference on Sunday, October 28 at the MGM Grand in Las Vegas.
Technology companies such as Google, Microsoft, Apple, Oracle and Twitter are making inroads in healthcare. But will their efforts gain traction and scale? At HLTH, representatives from some of these companies will take part in the healthcare transformation conversation across AI, voice, diabetes management and more.
As the second annual healthcare transformation conference HLTH approaches next month, here's a glimpse of some areas of interest that will be highlighted at the conference scheduled for October 27-30 at MGM Grand in Las Vegas.
In a runup to the much anticipated second annual HLTH conference in Las Vegas next month, here's a preview of the agenda for MedCity's annual patient engagement conference, which will take place October 28.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Here's a roundup of networking opportunities at the healthcare innovation conference in Las Vegas October 27-30 at the MGM Grand.
This year, MedCity is joining forces with HLTH to roll our annual ENGAGE conference into the HLTH conference, which will cast a spotlight on patient engagement on October 28.
At the second annual HLTH conference October 27-30 at the MGM Grand in Las Vegas, there will be a track devoted to mental and behavioral health — Mental and Behavioral Bridges to Health. Here's an overview of what to expect.
This year, MedCity News is teaming up with HLTH to roll our annual ENGAGE event into the HLTH conference. ENGAGE@HLTH will cast a spotlight on patient engagement on October 28. Here's a look at some of the programs at HLTH aimed at getting more women into executives positions and boardroom roles.
The effort by the nation's largest insurer to become the nation's largest employer of clinicians received FTC approval with an agreement to divest some of the company's holdings in the Las Vegas area to address antitrust issues.
